Does SODIUM, MONOBASIC, ANHYDROUS Cause Off label use? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Off label use have been filed in association with SODIUM, MONOBASIC, ANHYDROUS. This represents 20.6% of all adverse event reports for SODIUM, MONOBASIC, ANHYDROUS.
15
Reports of Off label use with SODIUM, MONOBASIC, ANHYDROUS
20.6%
of all SODIUM, MONOBASIC, ANHYDROUS reports
15
Deaths
10
Hospitalizations
How Dangerous Is Off label use From SODIUM, MONOBASIC, ANHYDROUS?
Of the 15 reports, 15 (100.0%) resulted in death, 10 (66.7%) required hospitalization, and 7 (46.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SODIUM, MONOBASIC, ANHYDROUS. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does SODIUM, MONOBASIC, ANHYDROUS Cause?
Vomiting (21)
Abdominal distension (20)
Methaemoglobinaemia (20)
Stress (17)
Abdominal pain (16)
Appendicitis (16)
Appendicolith (16)
Ascites (16)
Hyponatraemia (16)
Cardiogenic shock (15)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)